Litcius/Paper detail

Cyclosporine and omalizumab together: A new option for chronic refractory urticaria

Jorge Sánchez, Leidy Álvarez, Ricardo Cardona

2020The Journal of Allergy and Clinical Immunology In Practice26 citationsDOI

Topics & Concepts

OmalizumabRefractory (planetary science)Chronic urticariaMedicineDermatologyImmunoglobulin EImmunologyAntibodyMaterials scienceComposite materialUrticaria and Related ConditionsAutoimmune Bullous Skin DiseasesCoagulation, Bradykinin, Polyphosphates, and Angioedema
Cyclosporine and omalizumab together: A new option for chronic refractory urticaria | Litcius